Cargando…
Cost-effectiveness of activated protein C in real-life clinical practice
BACKGROUND: Recombinant human activated protein C (rhAPC) has been reported to be cost-effective in severely ill septic patients in studies using data from a pivotal randomized trial. We evaluated the cost-effectiveness of rhAPC in patients with severe sepsis and multiple organ failure in real-life...
Autores principales: | Dhainaut, Jean-François, Payet, Stéphanie, Vallet, Benoit, França, Lionel Riou, Annane, Djillali, Bollaert, Pierre-Edouard, Tulzo, Yves Le, Runge, Isabelle, Malledant, Yannick, Guidet, Bertrand, Le Lay, Katell, Launois, Robert |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556742/ https://www.ncbi.nlm.nih.gov/pubmed/17822547 http://dx.doi.org/10.1186/cc6116 |
Ejemplares similares
-
A balanced view of balanced solutions
por: Guidet, Bertrand, et al.
Publicado: (2010) -
Cost effectiveness analysis of drotrecogin alfa (activated) as a treatment for severe sepsis in hospitalised patients
por: Launois, R, et al.
Publicado: (2002) -
Effects of epinephrine compared to dobutamine-norepinephrine on gastric perfusion in septic shock
por: Seguin, P, et al.
Publicado: (2002) -
Editorial: Dynamics of Sensorimotor Interactions in Embodied Cognition
por: Vallet, Guillaume T., et al.
Publicado: (2016) -
Sepsis-associated delirium: the pro and con of C5a blockade
por: Annane, Djillali
Publicado: (2009)